Medicine and Health Sciences Commons^™

Sublingual Immunotherapy: Is It A Viable Option To Subcutaneous Immunotherapy When Treating Allergic Rhinitis?, David Ryan Kesterson

Physician Assistant Scholarly Project Posters

• Background: Allergic rhinitis (AR) is a very common debilitating disease that can be detrimental to one’s lifestyle, work, and home life. Immunotherapy is the only treatment option that has disease modifying capabilities with a proper therapeutic regimen. Subcutaneous immunotherapy (SCIT) was developed over 100 years ago and has been the gold standard in immunotherapy for many years in the United States. During these years many adverse reactions have been reported with SCIT along with non-adherence to total treatment. The introduction of sublingual immunotherapy (SLIT) over 20 years ago gave providers a promising alternative to SCIT.

• Method: A review …

Comparing Scit With Slit: For Treatment Of Ige Mediated Grass-Pollen Induced Rhinoconjunctivitis, Cory Heiser

Physician Assistant Scholarly Project Posters

• The peer review literature compared the effectiveness of treating allergic rhinitis (AR) with subcutaneous immunotherapy (SCIT) versus sublingual immunotherapy (SLIT) for allergen-induced rhinoconjunctivitis.

• The findings showed that there is no clear evidence of effectiveness between SCIT and SLIT for reducing AR symptoms. SLIT has been associated with cost savings with comparison to SCIT.

• The findings indicated that SLIT may be the preferred route for immunotherapy because of its convenience, comparable efficacy, safety and cost.